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INTRODUCTION
Hypertension  is  the  most  common  disease  –  specific  reason  for  which  many  visit 
physician. This is currently among the leading cause of mortality and morbidity in the world 
and is expected  to have an even greater impact on the health of public as more of the world 
becomes developed. 
In  addition  to  these  events  the  undetected  normotensive  hypertension  (Stephen  P. 
Glasser et al 2002) is a powerful risk factor that increases the individual (or) the population, 
who will develop wide variety of cardiovascular (CV) diseases. In the next decade more and 
more patients will become candidates for antihypertensive therapy. Hypertension is a sustained 
elevation of both systolic and diastolic Blood pressure. Essential hypertension is idiopathic and 
polygenic  in  origin  and  environmental  factors  are  very  much  involved.  Apart  from  few 
examples where single genetic basis of blood pressure regulation and its dysfunctions, essential 
hypertension is  the  sum of  interactions  between   multiple  environmental  & genetic  factors 
(Kurtz  TN et  al  1993).  We  can  also  recognize  that  the  development  and  maintenance  of 
hypertension may involve many systems including Cardiac, Vascular, Renal, Endocrine, and 
Nervous system, etc.  It is to be remember that the individual is named as hypertensive, the  
changes have already taken place in the CVS and other systems also. Hence it is necessary to 
detect (or) predict  normotensive hypertensive  concept as earlier as possible (Stephen et al 
2002). Even a moderate elevation of arterial pressure leads to reduced life expectancy. In most 
patients  with  essential  hypertension  there  is  a  strong  correlation  of  hereditary  factors  has 
proved  beyond  doubt  in  Okatomostrain  (rats).  Cardiac  and  vascular  changes  could  be 
considered risk factors for Cardiovascular disease rather than marker’s of established disease. 
These Cardiovascular risk factors are the change in the autonomic nervous systems regulation, 
changes  in  lipid  metabolism,  obesity,  insulin  resistance,  arterial  stiffness,  left  ventricular 
hypertrophy and renal disease etc.
The changes associated with ANS plays a fundamental role in adapting the heart and 
circulation  to  be  within  the  physiological  limits.  
It has been earlier accepted that baroreflex had little to do with long term control of blood 
pressure, but now there has been intense speculation on the role baroreflex mechanism along 
with  a long term BP control. Recent evidence projects that arterial baroreflex mechanisms do 
operate in normotensive hypertensive subjects at a slightly higher level.
The two limbs of in the regulation of  cardiovascular autonomic function, 1) base line 
autonomic level in HT and 2) is whether the normotensive HT differ in terms of blood pressure 
and HR responses to simple autonomic reflex test. An increase in cardiac out put (CO) or HR 
or both will increase the BP. Even in the case of normal peripheral resistance (PVR), the BP 
can  increase  due  to  above  cause  but  comes  back  to  normal  BP level  by  BP regulating 
mechanisms. But an increase in BP alone to the increase in PVR would also be offset by a 
reflex  decrease  in  CO.  But  this  phenomenon does  not  happen and the  increase  in  arterial 
pressure  is  maintained  and  it  makes  clear  enough  that  the  baroreflex  mechanism reset  to 
maintain an elevated arterial pressure. This is the essence elevated BP (Logo and Taylor 1994). 
Essential  hypertension is  an  impairment  of  auto regulation of  the  tissue blood flow.  This 
imbalance could be due to reduced vagal discharge from the Central Nervous system (CNS) 
(Or) increased sympathetic drive to the heart and vessels or preload increase in renal disease.
 The  changes  in  the  blood  pressure  is  also  effected  by  renal  volume  restoring 
mechanisms which are activated by baroreflex which is an important part of ANS. Changes is 
the BP is also brought about by the changes in the heart rate, which is very much controlled by 
parasympathetic discharge. The action of ANS is the most essential limb in the regulation of 
blood pressure. A balance control between SNS and PNS is necessary for maintaining cardio 
vascular changes in rest and in stress. So any alteration in ANS can pay an important role in the 
etiology of hypertension.
The present  study is  aimed for  evaluating the  cardiovascular  autonomic response in 
normotensive hypertensive subject using standard autonomic function test. In this study I have 
tested the recommendation of Ewings test for CVS ANF. This includes BP and HR response 
during supine rest, BP and HR response during quite standing (Ewings et at al 1985), HRV 
during deep breathing, Valsalva ratio during Valsalva maneuver, HR and BP changes during 
sustained isometric hand grip test (SIHG) and cold pressor test (CPT). Most of this test the 
baroreflex sensitivity.  The most important recent method of quantifying CVS ANF is by HRV 
using Power spectral density (PSD) analysis in Frequency domain and time domain. The ratio 
between PNS and SNS is  also calculated and results  give clear  idea about  sympathovagal 
balance. These above test are highly sensitive, recordable, reproduciable, non-invasive and less 
expensive. 
In the present study I have made an attempt to carry out the hypothesis of normotensive 
hypertensive concept by comparing the cardiovascular autonomic function variables of male 
offsprings of hypertensive  non-diabetic with male offsprings of non-hypertensive, non-diabetic 
parents.   
REVIEW OF LITERATURE
HISTORICAL PROSPECTIVE 
 Galen 1528 – showed vagosympathetic trunk
  Etienne’s Stephamis (1545) found out vagus and sympathetic nerves were separate nerves.
   Whytts (1751) – proved the essence of reflex actions.
 Weber & Weber 1845 – showed that HR is reduced by vagal stimulation; HR is increased 
by sympathetic stimulation.
 1898,  Langley introduced autonomic neurvous system 
 WB Canon 1851 – coined the term Homeostasis and the servo control.
 Karplus 1909 – proved to the world the role of hypothalamus in the regulation of Blood 
pressure.
 Herring 1920  found the  existence of Baroreflex activity.
 Alquist 1948 – found the receptors and sympathetic SNS.
 Hon and Lee St 1965 – Noted the fetal HR changes during fetal distress.
 Albert B Lewin (1966) – observed the changes in heart rate during Valsalva maneuver.
 Timothy  wheeler  1973 –  showed beat  to  beat  variations  in  HR as  a  measure  of  vagal 
function.
 Ewings et al 1973. Isometric hard grip test as sympathetic measure and  HRV analysis from 
short term ECG recording.
 Page and wathins 1977  devised  simple orthostatic test 
 Wolf et al 1977 – reduced HRV is a risk of sudden death in post Myocardial Infarction.
 Ewings & clark 1980 – found the quantitative ANFT. 
 Akselord et al 1981 – Introduced spectral analysis of HRV in short term and long term ECG 
recording.
 Cerulli 1991 – Spectral analysis of HRV in rats.
 Zieglec D 1992 – spectral analysis of HRV in humans.
 Low et al 1995 said about Postural  Orthostatic tachycardia syndrome (POTS).  tolarz K et 
a,l, 2002 HRV-2000 in that study power spectrum analaysis of HR in young people with 
family history of HT shown higher LF value in lying position  and less pronounded changes 
of HRV component after standing. 
 Reudeiger H.  et  al  have shown the PNS, SNS activation in  HRV in male hypertensive 
subjects in mental stress.
 ES Prakash et  al  2004 have studied HRV analysis  and standard ANFT in different  HT 
subject and shown that HRV deep breathing is a simple measure of vagal effects in HT, RPP 
provides a simple measure of overall HRV in HT.
 Jenning JR et al 2005 have studied ANF in white coat HT, where frequency domin in HRV 
being taken as the measure of ANF. They have shown that there is reduction in HF, greater 
LF/HF ratio.
 Karenyan et al 2003 have studied HT in male and followed them for 8-26 years.  Their  
conclusion was, life style modification is the basis for hypertension. 
 Pol Merteuriusz et al 2003 have shown persistence influence of sympathetic activity, after 
30mts of moderate physical exercises on HRV in patient with arterial hypertension.
 Ronnernelerh et al 2003 have shown circadian profiles of HRV time domain analysis. They 
found  that  overall  HRV is  diminished at  night  and  increased  during  day  time.  As  age 
advances the HRV decreases gradually.
 Maver JR et al 2004 have studied ANFT with normotensive subject with family history of 
Hypertension.  Normotensive subjects  with  family  history  of  hypertension  showd higher 
resting SBP, a decrease HF band, LF is very much increased LF/HF ratio increased.
 Cybulski G et al 2003 studied influence of age on  the immediate response to the active 
orthostatic  test.  There was alteration in HR during study analyzed by ECG using Liner 
regression model. They obtained no correlation between BMI and HR.
 Perini , veisessteims A et al 2003 studied HRV and autonomic activity at rest and during 
excerise in various physiological condition. The powers of HF and LF components of HRV 
have  been  shown  to  estimate  sympatho  vagal  activity.  HF  modulation  is  brought  by 
increased respiratory activity. LF nu changes are seen from lying to standing position in 
normalized unit (nu).
 Srinivas K and Sucharita S, et al 2002 have showed the HRV on standing in three age 
groups of male subject,  HRV is highest in young and children. HRV was low in old age.  
 Sacha, J Pluta W et al 2005 different methods of HRV analysis reveal. The type of signals  
that  determines  the sign of  correlation among total  power,  LF and HF.  The parameter  
obtained from the corrected signals, normalized quantities and LF/HF reveal a consistent 
relationship with heart rate.  parameter obtained from corrected signals, nu quantities and 
LF/HF ratio reversal a consistent relation ship with heart rate.
 Stolarz K et al, 2002 HRV-2000 in that study power spectrum analaysis of HR in young 
people  with  family  history  of  HT shown  higher  LF  value  in  lying  position   and  less 
pronounded changes of HRV component after standing. 
AUTONOMIC REGULATION OF CARDIO VASCULAR FUNCTION Autonomic 
nervous system through the autonomic reflex that regularly respond to internal and external 
stimuli  modulate the  activity  of  the  body’s organs.  ANS is  like any other  somatic  nervoes 
system, is well organized on the basis of reflex arc. This is fully seen in CVS. ANS depends on 
the functional integrity of multiple autonomic reflex arc. In simple terms the ANS consist of 
afferent path ways, central processing system and efferent pathways; ANS out flow is divided 
into  two  components.  The  throacolumbar  sympathetic  out  flow  and  craniosacral 
parasympathetic out flow, whose effects are mostly antagonistic and whole balance activates to 
produce homeostasis in any systems. The peripheral out flow of the ANS are brought out by 
pregangliogenic and postganglonic nerves.
Autonomic innervations of cardio vascular system
The heart and vascular system are innervated by both parasympathetic and sympathetic 
nerves. The predominant supply of vagus is to the pace maker and conducting system and the 
sympathetic supply are more for cardiac muscle and vascular system. So the changes in the 
heart rate are predominantly modulated by the vagus and the contractility of cardiac muscle is 
brought by sympathetic pathway ( Jalifc et al 19954).  
Although  some  local  factors,  such  as  temperature,  hormone  changes  and  stretch  of 
tissues can change the heart rate, the ANS is the principle way by which the heart rate can be  
controlled effectively.
We understand that the average resting HR is 70 beats/min in normal adults at rest and is 
very  much greater  in  fetus  and in  children.  During  sleep  the  HR decreases  around 10-20 
beats/min and during emotional status and muscular exercise (any stress) the HR may go upto 2 
times of the resting HR or more. The HR increase is due to the decrease in PNS and with 
increase in SNS. Though the two nerves act on SA node. The vagus in predominant in healthy  
and  resting  individuals.  When  healthy  individual   is  given  atropine,  a  muscarnic  receptor 
antagonist that blocks parasympathetic (PNS) effects and so the heart rate increases sufficiently. 
If a healthy person is given propanolol, a β  adrenergic receptor antagonist that blocks SNS, so 
the heart rate decreases only slightly. It is interesting to note that when both divisions of ANS is 
blocked the heart rate in young adults averages about 100 beats/min (Ganong. WF). The rate 
that prevails after complete ANS blockade is called the intrinsic heart rate. This is the most 
important concept that we have to understand. During the physiological stress however there is 
decreased parasympathetic activity and relative or absolute increase in sympathetic activity that 
causes changes in the CV function. 
AUTORHYTHMICITY 
The heart has its own inherent activity which is seen in  spontaneously firing pacemaker 
cells in the wall of the right atrium. These cells are specialized cardiac muscle cells with scanty 
contractile  fibers  with  large  number  of  gap  junctions.    These  cells  have  their  membrane 
potential that after each impulse comes back to firing level what is called as prepotential (or) 
pace maker potential. At the peak of each impulse, potassium IK efflux begins and brings 
about  repolarization.  IK  then  delines,  and  has  efflux  decreases,  the  membrane  begins  to 
depolarize,  forming the  first  part  of  prepotnetial,  Ca2+ challnels  then  open.   The  calcium 
current (Ica)  due to opening ‘T’ (Transchannels  complete the prepontial  followed by entry 
through L (Longlasting) channels to produce the impulse.  
PARASYMPATHETIC PATHWAY
The cardiac parasympathetic fibers originate in the medulla oblongata cells that lie in the 
dorsal motor nucleus of the vagus (or) the nucleus ambiguous. In humans the vagal fibers pass 
through the neck close to the common carotid arteries and then through the mediastinum to 
synapse with the post ganglionic cells. The vagal post ganglionic pathways go across the right 
atrial  epicardium to the SA node. These cells are located either on the epicardial surface within 
the wall of the heart.  Most of the cardiac ganglion cells are located near the SA node and 
atrioventricular (AV) conduction tissue.  The right vagus nerve affects predominantly SA node. 
Stimulations of this nerve slows SA nodal firing and can even stop it for several seconds. The 
left vagus nerve mainly inhibits AV conduction tissue to produce various degrees of AV blocks. 
But there is also overlapping,  of left and right vagal fibres. Because of this overlapping, left  
vagal  stimulation  also  depress  the  SA node,  and  right  vagal  stimulations  impedes  the  AV 
conduction.  Among  right  and  left  vagus,  the  right  vagus  predominately  dominates  the 
pacemaker cells of the heart in determining the heart rate changes. 
SYMPATHETIC PATHWAYS
The cardiac sympathetic fibers originate in the intermediolateral horn cells (IML) of the 
upper six thoracic segments and lower two cervical segments of the spinal cord. The fibers 
emerge from the spinal column through white communicating branches and enter paravertebral 
chains of ganglia. The preganglionic and post ganglionic nerves synapse mainly in the stellate 
(or) middle cervical ganglia. In the mediastinum, the post ganglionic sympathetic fibers and 
preganglianic  parasympathetic  fibers  join  to  form a  complex plexus  of  the  mixed efferent 
nerves to the heart.
The post ganglionic cardiac sympathetic fibers in this plexus approach the base of the 
heart along the adventitial surface of the great vessels (Schwartz PJ e al 1990). On entering the 
base of the heart, the fibers are distributed to the various chambers as an extensive epicardial 
plexus.  They  then  penetrate  the  myocardium  along  the  coronary  vessels.  The  left  side 
sympathetic fibers are distributed left side of heart having predominant role on the myocardial 
contractility. The right side sympathetic distribution carries the changes in the heart rate. There 
is also extensive crossing over of these fibers.
OVERALL INTEGRATION OF ANS
All  the  system in  our  body  are  well  integrated.  ANS is  a  perfect  example  of  well 
integrated System. They receive and transmit information. Since there are so many variables 
associated with this system, it is not that much easy to study the complex integration. Since 
they are associated with vital function, it is necessary to describe those variables which are 
known to be related and to develop a methodology by which these variables may be examined, 
monitored and treated if necessary.
The control mechanisms of this reflexogenic system exist at various levels of neural 
axis.  In  the  earlier  studies  supra  segmental  influence  upon  segmental  level  was  done.  At 
present,  available  literature  provides  information  on  the  vital  centers  in  pontomedullary 
mesencephalic reticular  formation and also cerebral  neocortical  and paleocortical  structures 
which integrate them. These regulator systems include simple reflexes in the brainstem and 
spinal cord as well as complex long circuit pathways through the higher brain centers. Higher 
centre of regulatory functions are located in the reticular formation of the brainstem and nuclei 
of the hypothalamus with a great influence from the limbic areas and the cerebellum. The very 
fact that, every activity of the nervous system is associated with ANF and every activity of the 
cortex has a profound effect upon the autonomic regulatory controls. In the present study I have 
sincerely attempted to find out the CV ANF, in normotensive hypertensive subjects.
ROLE OF GENETICS IN HYPERTENSION
Introduction 
Primary  (or)  essential  HT  is  defined  as  a  high  blood  pressure  where  no  obvious 
secondary causes, such as renal disease, adrenal tumors, drug therapy (or) diabetics have been 
identified. Given a large number of environmental,  behavioural, and genetics factors that can 
potentially influence blood pressure. Essential HT covers a wide range of underlying cause and 
although it would be extremely useful to subdivide primary HT for the purpose of treatment 
parameters. The genetic compliment of an individual may determine his / her ability to respond 
to such change to impinge on environmental factors.
Work by various investigators to isolate a “hypertensive gene” or “group of genes” have 
been going on for many years. Genetic effects of HT is polygenic in nature. This means that  
there are genetic loci which influence BP. Abnormalities in the angiotensin gene have been 
identified by (Caulfield and co-workers) provide evidence to link mutations in the angiotensin 
gene  to  the  pathogenesis  of  essential  hypertension.  The  possible  genetic  link  between  the 
presence  of  insulin  resistance  and  the  development  of  hypertension  has  been  provided 
(Ferranmini et al 1987).  Candidate genes are identified in number of ways. In some cases, a 
simple Mendelian form of HT can be identified by pedigree analysis. Detailed linkage analysis 
may then reveal the chromosome, the sub-chromosomal region, or even the gene most likely to 
be involved in HT, may be the result of small increments in the Blood pressure may be due to a  
number of contributing variants. Each of these may vary not only in phenotype but may also be 
affected by polymorphic allele frequencies, low peniterance and the epistatic effects of other 
genes.
Genome wide lineage analysis suggests that different sets of genes contribute to HT in 
different  ethinic  groups  and  the  precise  analysis  is  difficult  in  humans  because  of  their 
heterogeneous genetic background.  Recently developed micros-satellite  database for  human 
(Colin JR e al 2003), greatly aid whole genome scans. Any mutation that causes sustained salt  
retention concomitantly increase water retention and will raise blood pressure. The other way is 
also true causing hypotension (Physiological review 1986).
With rapid advances in functional genomics and proteomics that the majority of genes 
would be identified and mapped in the whole genome sequencing programs and subsequently 
will be classified and have functions assigned to them. Finally it is the interactions between 
gene products that mediate physiologic response. The delineation of a gene profile that will  
predict who will develop hypertension is very near. Data from the on going many studies may 
very soon, will lead to the identification of such genes within the next few years.
HEAR RATE VARIABILITY
Introduction
There  has  been  no  quantitative  marker  for  –  Cardiovascular  Autonomic  Function. 
Studies in the last 30 years has shown a great significance between ANS and CV morbidity, 
including sudden death and malignant arrhythmias (Levymn et al 1994).  Heart rate variability 
represents  the  hallmark  of  such  markers.  At  present  may  commercial  devices  provide 
automated measurement of HRV. Physiologist and clinical cardiology research scholars have 
made use of these instruments. But the precise measurement and meaning of HRV analysis 
being  more complex. European society of cardiology and North American society of pacing 
and electrophysiology have contributed a Task force to develop appropriate standards. In this 
study  I  have  followed  the  recommendations  and  guide  lines  of  The  Task  force  1996 
(Circulation 1996).
Back ground
The clinical use of HRV was well recognized when Hon and Lee  in 1965 studied that, 
fetal distress was preceded by alterations in HRV before any notable change occurred in the 
heart rate itself. During 1970’s (Ewing et al 1970)  made simple bedside test of short term RR 
difference to detect a neuropathy in diabetic patients. In 1981 Akselrod et al (33) introduced 
first  power  spectral  analysis  of  heart  rate  fluctuations  to  quantitative  evaluation.  The 
understanding of  ANF on the  basis  of  RR interval fluctuations  in the heart  rate  is  by two 
methods. 
 Frequency domain methods 
 Time domain methods.
Frequency domain methods 
Though there are various spectral methods for studying RR tachogram, Power spectral 
density  (PSD)  analysis  gives  the  fundamental  information  of  how  the  power  (Variance) 
distributes  as  a  function  of  frequency  (Rottamann  et  al  1990).  By  proper  mathematical 
algorithms and estimate of true Power spectral density can be obtained. They are 
1) Non-parametric method
2) Parametric method 
The advantages of non parametric methods are 
a) The simplicity of algorithm used fast fourier transform (FFT)
b) High processing speed
Spectral Components
Short term recordings: In this study we have used only short time HRV that is for 5mins. The 
three  main  components  are  distinguished  in  a  spectral  calculation  from  short  term  ECG 
recording are (Akeslred S et al 1981) VLF, LF and HF
VLF - Very low frequency 
LF - Low frequency
HF - High frequency
The distribution of power and central frequency of LF and HF are not fixed but may vary in relation to 
changes  in  autonomic  modulations  of  the  heart  period  (Paganim  et  al  1986).  The  physiological 
explanation for VLF component is much less defined and there changes brought about by changes in 
temperature and ACE inhibitors. The measurement of VLF, LF and HF power are usually made in 
absolute values of power (millisecond squared). Their frequency range is given as follows.
Range (Hz)
VLF 0.0 - 0.04
LF 0.04 - 0.15
HF 0.15 - 0.4
Flow chart summarizing individual steps used when recording and processing the ECG signal 
in order to obtain data for HRV analysis.
LF  and  HF  are  also  measured  in  normalized  units(Mallinai  A et  al  1991),  which 
represents the relative value of each power component in proportion to the total power mines 
the VLF component. So the representation of LF and HF in normalized units emphasis the 
controlled  and  balanced  behaviour  of  the  two  branches  of  ANS.  The  usefulness  of 
normalization,  is to minimise the effect of changes in total power and the value of LF and HF 
components.  In  this  study,  we  have  quoted  absolute  value  for   LF  and  HF  and  also  the  
normalized units for LF and HF. The ratio of LF and HF units give the autonomic modulation. 
If the modulations are constant, the interpretation of the results of frequency analysis is less 
well defined. In our physiological mechanism the heart period modulations are taking place 
every  movement  and so  these  changes  are  seen  in  LF and HF components.  Thus  spectral 
analysis  are taken on the entire 24-hrs period as well as spectral  results  are obtained from 
shorter segments (5mints) averaged over entire 24hrs also (Furlan R et al 1990). It should be 
remembered that the components of HRV provide measurement of the degree of autonomic 
modulation rather than of the level of autonomic tone. 
PHYSIOLOGICAL CORRELATIONS OF HRV
We know that the cardiac automaticity is intrinsic to pacemaker tissue; heart rate and 
rhythm being largely under the control of autonomic systems. The focus of this study is the 
oscillations in the interval  between consecutive heart  beats  as  well  as  oscillations between 
consecutive  instantaneous  heart  rate.  “Heart  rate  variability  (HRV)”  has  become  the 
conventionally accepted term to describe variations of both instantaneous heart rate and RR 
intervals. To describe oscillation in consecutive cardiac cycles, other terms have been used in 
the literature, for example, cycle length variability, heart period variability, RR variability, 
and RR interval tachogram, and they are more appropriately emphasize the fact that it is the 
interval between consecutive beats  that  is  being analyzed rather than the heart  rate per  se.  
however, these terms have not gained as wide acceptance as HRV; thus, I have used the term  
HRV in this document.
COMPONENTS OF HRV
RR interval at resting conditions represents a fine tuning of beat (Levy MN et al 1994) – 
to  beat  control  mechanisms.  Vagal  afferent  stimulations  lead  to  reflex  excitation  of  vagal 
efferent activity and inhibition of sympathetic efferent activity. The opposite reflex effects are 
mediated by sympathetic  activity.  Efferent  vagal  activity  also appears  to  be  under “Tonic” 
restraint by cardiac afferent sympatheties activity  (Cerati D et al 1991). Efferent sympathetic 
and  vagal  activities  directed   to  the  sinus  node  are  characterized  by  discharge,  largely 
synchronous  with  each  cardiac  cycle  that  can  be  modulated  by  central  (vasomotor  and 
respiratory centers) and peripheral (oscillation in arterial pressure and respiratory movements) 
oscillators. These oscillators generate rhythmic fluctuations in  efferent neural discharge that 
manifest as short-and long –term oscillation in the heart period. Analysis of these rhythms may 
permit inferences on the state and function of (a) the central oscillators, (b) the sympathetic and 
vagal efferent activity, (c) humoral factors, and (d) the sinus node. 
An understanding of the modulatory effects of neural mechanisms on the sinus node has 
been enhanced by spectral analysis of HRV (Mallini A et al 1991). The efferent vagal activity is 
a major contributor to the HF component, as seen in clinical and experimental observations of 
autonomic maneuvers such as electrical vagal stimulation, muscarinic receptor blockade, and 
vagotomy. More controversial is the interpretation of sympathetic modulation (especially when 
expressed in normalized units) and by others as a parameter that includes both sympathetic and 
vagal influence. This discrepancy is due to the fact that in some conditions associated with 
sympathetic excitation, a decrease in the absolute power of the LF component is observed. It is 
important  to  recall  that  during  sympathetic  activation  the  resulting  tachycardia  is  usually 
accompanied by a marked reduction in total power, whereas the reverse occurs during vagal 
activation.  When  the  spectral  components  are  expressed  in  absolute  units  (milliseconds 
squared), the changes in total power, influence LF and HF in the same direction and prevent the 
appreciation of the fractional distribution of the energy. This explains why in supine subjects 
under controlled respiration, atropine reduced both LF and HF and why during exercise LF is 
markedly reduced. This concept is exemplified in showing the spectral analysis of HRV in a 
normal  subject  during  control  supine  condition  and  900 head-up  tilt(Montano  et  al  1994). 
Because of the reduction in total power, LF appears as unchanged if considered in absolute 
units. However, after normalization an increase in LF becomes evident. Similar result apply to 
the LF/HF ratio also.
LF and  HF can increase  under  different  conditions.  An  increased  LF (expressed  in 
normalized units) is observed during 900 tilt, standing, mental stress, and moderate exercise in 
healthy  subjects,  and  during  moderate  hypotension,  physical  activity,  and  occlusion  of  a 
coronary artery or common carotid arteries in conscious dogs. Conversely, an increase in HF is 
induced by controlled  respiration,  cold  stimulation  of  the  face,  and rotational  stimuli.   To 
conclude  HRV  analysis  has  got  wide  application  in  clinical  medicine  such  as  diabetic 
neuropathy,  Post  Myocardial  infarction  (sudden  death,  malignant  arrhythmias),  autonomic 
function  disturbances,  myocardial  dysfunctions,  CVS  drug  therapy,  vagal  dominance 
identification, exercise training and many other clinical disorders. 
AIM AND OBJECTIVES OF THE STUDY
1) To compare the cardiovascular autonomic function in male offsprings of (18 to 25 years) 
non-hypertensive and non-diabetic parents to the male offsprings of hypertensive, non-
diabetic parents by 
i. BP and HR during supine rest to BP and HR response to standing, HRV during deep 
breathing  and  Valsalva  ratio  in  Valsalva  maneuver.  HR  and  BP response  during 
sustained isometric Hand Grip Test (SIHG) and during Cold Pressor Test (CPT).
2) To  compare  the  usefulness  of   Heart  Rate  Variability  Analysis  to  cardiovascular 
autonomic function test in either subjects.
MATERIALS AND METHODS
Subjects : 
The subjects were undergraduate male students of Stanley Medical College Chennai. 
The students were briefed about the study procedure and a written and oral consent was 
obtained from them.  
They were given a printed questionnaire (Appendix A) and based upon the written replies they 
were divided into two groups.
Group Abbreviation 
used
No. of 
Subjects
Offsprings of Non Hypertensive, 
non diabetic parents. (Control)
ONHTP 25
Offsprings of Hypertensive, non 
diabetic parents (Study Group)
OHTP 25
INCLUSION CRITERIA 
1) Healthy male individuals of 18 – 25 years.
2) Free from CVS and any other chronic illness.
3) Non smokers, non alcoholic, not on any drugs.
EXCLUSION CRITERIA
1) History  of any neural or endocrine illness 
2) History of autonomic dysfunction.
EXPERIMENTAL PROTOCOL 
The tests  were carried out in the neurophysiology of  the Department of Physiology, 
Stanley Medical College, Chennai between 10.00 am and 1.00 pm. The laboratory environment 
was quiet, the temperature between 25 - 28 degrees Celsius and the lighting subdued. Subjects 
were  asked to  empty their  bladder  before  the  tests.  The tests  did not  involve intravascular 
instrumentation or administration of any drugs at any stage. 
EQUIPMENT
ECG was acquired using RMS Polyrite D hardware 2.2 (India), an instantaneous heart 
rate  at  RR  intervals  were  continuously  plotted  using  RMS  2.2  software  on  a  Microsoft 
Window-based PC. The RMS polyrite software 2.2 helps to save multiple records and provided 
with  additional  filter  settings,  calculation  tools,  automated  analysis  and  auto  report 
generation.  Respiratory  movements  were  recorded  using  respiratory  belt  which  analysis 
inspiration and expiration. Blood pressure was measured using the automated non-invasive BP 
monitor (Planet 50)  L & T India. This measures BP by the oscillometric method. A standard 
adult – size cuff measuring 23 cm by 12 cm was used for all subjects. 
METHODOLOGY OF CARDIOVASCULAR ANFT
The  subjects  were  made  to  sit  in  the  lab  for  10min  to  get  accustom to  the   new 
environment after emptying the urinary bladder. The subjects have been clearly instructed not 
to have Coffee, Tea or cool drinks 1½ hours before test. After through clinical examination 
(Appendix B) to rule out any acute or chronic illness also for any autonomic dysfunction, then 
their height in meters and weight in Kg measured.  The students were then explained about the 
CV ANFT procedure.   Then the  battery  of  standard  CV ANFT carried  out  which  are   as 
follows.
Procedure :
1) Electrodes were fixed in the following position after cleaning the site with sprit to record the 
ECG
Electrode Position
Exploring electrode Left shoulder
Exploring electrode Right shoulder
Reference electrode Right leg
2)  Respiratory  belt  was  tied  around  the  chest  at  the  level  of  nipple  to  record  respiratory  
movement.
3) The electrodes and the respiratory belt were connected to RMS polyrite D equipment.
4) Blood Pressure cuff was tied to the right upper arm and connected to an automated non 
invasive BP monitor (Planet 50), L&T India.
i) Base line BP, HR & HRV : 
ECG was recorded for 10mins to determined the HRV at supine rest with the eyes closed 
with normal quite respiratory movement (12-16/min). Base line BP, was recorded at the end of 
10mins at supine position.
ii) BP, HR & HRV response to standing : 
After recording in the supine position the subjects were asked to stand without support 
on a wooden plank  within 3 seconds and his BP and HR were recorded at the end of 5 sec, 2 
mins and 5 mins after assumption of standing position.
iii) HRV During Deep Breathing
After recording the standing position the subject was asked to lie down comfortably in 
the supine position.  He was then instructed to breath slowly and deeply at a rate of 6 breath per 
minute in such a way that  he takes 5 seconds for  each inspiration followed 5 seconds for 
expiration.  The entire procedure was monitored on the screen
iv)  Heart Rate Changes During Valsalva Maneuver.
I have made the subject to sit comfortably on a chair.  I have instructed them to blow the 
air through the tube of the mercury manometer to keep the mercury pressure at 40mm and 
sustained at 40 mmHg for 15 sec.  I have repeated this test 3 times with time interval of 3 
minutes each.  Valsalva ratio (VR) was obtained between the maximum RR and the minimum 
RR for each event and the maximum ratio was  taken as the VR value.  
V) BP and HR changes during Sustained Isometric Handgrip Test (SIHG)
Using hand dynamometer, I asked the subjects to produce 30% of maximum voluntary 
contraction on the non-dominant hand atleast for 60 sec.  BP was recorded on the other hand at 
the end of 1 minute of sustained handgrip.  
VI) BP and HR Changes During Cold Pressor Test (CPT).
The subject was seated comfortably and his left hand was immersed upto the wrist in the 
cold water 10+2 degrees Celsius for 1 minute.  At the end of 1 minute BP was recorded on the 
other hand.  Although the recommendation for CPT is 4OC but our climatic condition allowed 
us to do at 10oC for 1 minute.
TECHNIQUES OF HEART RATE VARIABILITY ANALYSIS :
A detailed account of techniques of heart rate variability analysis was mentioned in the Task 
force report of the European Society of Cardiology, 1996.  Briefly, ECG was acquired at a rate 
of 1000 samples per second using RMS polyrite 2.2 software for atleast 330 seconds during 
supine at rest and then standing. The ECG was also recorded during deep breathing, isometric 
handgrip and cold pressor test.  I checked the ECG for artifacts and ectopics.  I have applied 
linear interpolation for NN intervals i.e. (Normal to Normal RR intervals).  HRV analysis in 
frequency domain method was done by HRV analysis V 1.1 software.
FREQUENCY DOMAIN ANALYSIS
The artifact  free  RR interval  tachogram (256  seconds)  was  resampled  at  2  Hz  and 
detrended, its mean removed and padded with zeros to obtain a 1024 point time-series.   A 
Hanning window was applied to minimize special leakage and the series was analysed by linear 
fast Fourier transformation. A 512 point FFT spectrum with a frequency resolution of 3.9 mHz 
was  obtained.   The  spectrum was  further  processed  by  applying  a  smoothing  function  (a 
smoothing factor of 7) to identify spectral densities contributing to cyclical behaviour of the 
series.
RR interval variations occurring in the frequency range 0-400mHz  were chosen for 
analysis  and  a  power  spectrum  obtained  by  squaring  the  magnitude  of  the  Fast  Fourier 
transform in this frequency range (Sands e al.  1989). Low frequency (LF) spectral power and 
high frequency (HF) spectral power of RR intervals were obtained by integrating the power 
spectrum from 40 mHz – 150 mHz and 150 – 400 mHz respectively (Sands et al, 1989). The  
LF/HF ratio was derived as the ratio of low frequency and high frequency spectral powers 
expressed in dimensionless units.  Total power was calculated as the sum of the LF and HF 
powers.  Power in the very low frequency range (VLF) (4-40 mHz) was not analysed since it is  
not reliably assessed in 5 minute recording (Sand et al., 1989).  The LF and HF spectral powers 
in normalized units (nu) were calculated as shown below in the table. 
Frequency – domain measures of HRV
Index Units Description
LF Power ms2 Power in the frequency band 0.04 – 0.15mHz
HF Power ms2 Power in the frequency band 0.15 – 0.4 Hz
Total Power ms2 Power in the band 0.04 – 0.4Hz
LF / HF ratio - Ratio of LF to HF powers
LF nu - LF power / (LF power + HF power)
HF nu - HF power / (LF power + HF power)
All  these  derivations  comply  with standards  recommended by the  Task force  of  the 
European  Society  of  Cardiology  and  the  North  American  Society  for  Pacing  and 
Electrophysiology (1996).
ETHICAL CONSIDERATIONS :
The  study  was  approved  by  Ethical  Committee,  Stanely  Medical  College,  Chennai. 
OBSERVATION 
Table1
Anthropometry of subjects (Age, Weight & Height are expressed 
as mean + SD)
 
Group
N = 25 N Mean SD
Independent
t-test
Age Control 25 19.72 1.90
t=1.82 P=0.07
Study 25 20.84 2.41
Height 
(Mts)
Control 25 1.6816 .051
t=1.71 P=0.09
Study 25 1.7120 .072
Weight 
(Kg)
Control 25 68.82 10.62
t=1.93 P=0.06
Study 25 70.52 11.30
BMI Control 25 24.40 3.15
t=1.37 P=0.18
Study 25 24.055 3.52
Table 2
Resting Mean blood pressure and heart rate in supine position.  Data are expressed as 
mean +  SD, 95% confidence interval of the mean.
Group N Mean Std. Deviation
Independent
t-test
HR Control 25 68.66 10.47 t=1.89 P=0.28Study 25 71.97 11.00
SBP Control 25 103.12 7.09 t=1.47 P=0.15Study 25 106.48 8.99
DBP Control 25 65.76 7.29 t=1.89 P=0.07Study 25 69.80 7.81
PP Control 25 37.20 7.76 t=0.67 P=0.51Study 25 38.72 8.28
RPP Control 25 7089.36 1228.35 t=1.58 P=0.12Study 25 7675.92 1397.72
Table 3
Mean Heart  rate and blood pressure response after 2 minutes of standing. Data are 
presented as mean + SD, 95% confidence interval of the mean.
Parameters Group
n = 25
Rest 2 Minutes
after 
standing
Paired t test
HR
(bpm)
Control 68 + 10 81 + 10
t = 6.12
P = 0.001
Study 71 + 11 83 + 11
t = 5.07
P = 0.001
SBP
(mmHg)
Control 103 + 7 112+ 10
t = 4.22
P = 0.001
Study 106 + 8 112+ 9 t = 3.44
P = 0.001
DBP
(mmHg)
Control 65 + 7 76+ 8
t = 4.66
P = 0.001
Study 69+ 7 76+ 6
t = 4.57
P = 0.001
RPP
(mmHg 
bpm)
Control 7089 + 1228 9243+ 1717
t = 6.35
P = 0.001
Study 7675 + 1397 9468 + 1745
t = 5.73
P = 0.001
Changes during standing were analyzed by Student’s Paired ‘t’ test.
Table 4
Mean Percentage Changes in heart rate and blood pressure during standing compared 
with baseline.  Data are represented as mean + SD, 95% confidence interval of the mean.
HR Group N Mean (%) Std. Deviation
Independent
t-test
HR immed. Control 25 36.57 19.26 t=3.18 P=0.03Study 25 19.65 18.28
HR 2 min. Control 25 20.53 17.25 t=0.49 P=0.62Study 25 18.02 18.40
HR 5 min Control 25 15.28 15.61 t=1.05 P=0.29Study 25 10.34 17.63
SBP Group N Mean (%) Std. Deviation
Independent
t-test
SBP immed. Control 25 12.08 12.04 t=2.30 P=0.03Study 25 32 22.55
SBP 2 min Control 25 9.45 11.06 t=1.16 P=0.25Study 25 6.21 8.63
SBP 5 min Control 25 7.15 10.30 t=1.19 P=0.24
Study 25 3.94 8.56
DBP Group N Mean (%) Std. Deviation
Independent
t-test
DBP  immed. Control 25 19.69 19.07 t=2.66P=0.01Study 25 8.31 9.59
DBP 2 min Control 25 17.90 19.27 t=1.63P=0.11Study 25 10.62 11.29
DBP 5 min
Control 25 14.17 18.04 t=1.62
P=0.11Study 25 7.04 12.48
RPP Group N Mean (%) Std. Deviation
Independent
t-test
RPP immed. Control 25 53.32 28.98 t=3.71P=0.001Study 25 21.11 32.30
RPP 2 min Control 25 32.69 28.39 t=1.00P=0.32Study 25 25.42 22.38
RPP 5 min
Control 25 23.92 23.88 t=1.42
P=0.16Study 25 14.83 21.20
Changes during standing were analyzed by Student’s paired ‘t’ test.
Table 5
Mean Heart Rate and blood pressure changes during sustained isometric handgrip.  Data 
are presented as mean + SD.
Group Parameters N Mean Std. Deviation Paired t-test
Control
HR (Rest) 25 68.66 10.47 t=8.15
P=0.001HR (SIHG) 25 87.00 6.95
SBP (Rest) 25 103.12 7.09 t=10.67
P=0.001SBP (SIHG) 25 123.08 11.07
DBP (Rest) 25 65.76 7.29 t=13.82
P=0.001DBP (SIHG) 25 88.00 6.72
RPP (Rest) 25 7089.36 1228.35 t=11.78
P=0.001RPP (SIHG) 25 10722.16 1381.18
Study
R_HR (Rest) 25 71.97 11.00 t=6.68
P=0.001HR (SIHG) 25 84.76 11.38
SBP (Rest) 25 106.48 8.99 t=4.59
P=0.001SBP (SIHG) 25 118.52 12.86
DBP (Rest) 25 69.80 7.81 t=4.33
P=0.001DBP (SIHG) 25 79.56 9.33
RPP (Rest) 25 7675.92 1397.72 t=7.21
P=0.001RPP (SIHG) 25 10082.52 1902.40
Changes at rest and after the test were both compared with by Student’s paired ‘t’ test. 
Table 6
Mean Heart Rate and blood pressure changes during 
Cold Pressor Test. 
Group Parameters N Mean Std. Deviation Paired t-test
Control 
RHR (Rest) 25 68.66 10.47 t=8.62
P=0.001HR (CPT) 25 88.40 4.19
SBP (Rest) 25 103.12 7.09 t=7.28
P=0.001SBP(CPT) 25 124.64 14.84
DBP (Rest) 25 65.76 7.29 t=9.66
P=0.001DBP (CPT) 25 84.32 9.34
RPP (Rest) 25 7089.36 1228.35 t=9.13
P=0.001RPP (CPT) 25 11040.40 1547.19
Study 
R_HR (Rest) 25 71.97 11.00 t=7.26
P=0.001HR (CPT) 25 87.36 10.67
SBP (Rest) 25 106.48 8.99 t=4.88
P=0.001SBP (CPT) 25 121.00 12.90
DBP (Rest) 25 69.80 7.81 t=6.12
P=0.001DBP (CPT) 25 81.24 8.41
RPP (Rest) 25 7675.92 1397.72 t=8.87
P=0.001RPP (CPT) 25 10585.08 1847.39
Changes at rest and after the test were both compared with by Student’s paired ‘t’ test. 
Table 7
Control Deep Breathing for 1 minute
Group N Mean Std. Deviation Student t-test
DB max/min
RR Interval
Control 25 1.342 0.13 t=3.10
P=0.003Study 25 1.198 0.18
Changes during controlled breathing were analyzed by Student’s paired ‘t’ test.
Table 8
Valsalva Ratio  in Valsalva Maneuver
Group N Mean Std. Deviation Student t-test
VR max / min
RR Interval
Control 25 1.244 0.13 t=3.59
P=0.001Study 25 1.120 0.10
Changes during valsalva maneuver were analyzed by Student’s paired ‘t’ test.
Table 9
30/15 ratio on immediate standing
 Group N Mean
Std. 
Deviation Student t-test
30/15 sec RR 
Interval
Control 25 1.288 0.14 t=3.77
 P=0.001Study 25 1.108 0.18
Table 10
Heart rate and heart rate variability indices during supine rest.  Data are expressed as 
mean + SD, 95% confidence interval 
of the mean.
Parameters Group N Mean Std. Deviation
Student
t-test
HR Control 25 68.66 10.47 t=1.09
P=0.28Study 25 71.97 11.00
MEAN (RR) 
(ms)
Control 25 881.92 125.45 t=1.10
P=0.28Study 25 824.54 227.97
SDNN (ms) Control 25 52.32 18.70 t=0.13
P=0.89Study 25 53.24 27.93
LF power 
(ms2)
Control 25 363.44 235.30 t=1.14
P=0.26Study 25 587.32 947.50
HF power (ms2) Control 25 506.64 419.67 t=0.94
P=0.35Study 25 398.88 387.71
TOTAL power 
(ms2)
Control 25 870.08 602.51 t=0.43
P=0.67Study 25 986.20 1225.69
LFnu Control 25 32.14 33.49 t=1.04
P=0.30Study 25 44.79 15.44
HFnu Control 25 55.197 15.44 t=2.31
P=0.03Study 25 44.42 17.41
LFHF ratio Control 25 1.04 .98 t=1.99
P=0.05Study 25 1.69 1.32
NN50 Control 25 106.40 61.03 t=21.5
P=0.04Study 25 71.28 54.47
Table 11
Mann-Whitney Test
Test Statistics(a)
 nn50_hrv
Mann-Whitney U 291.500
Wilcoxon W 616.500
Z -.408
Asymp. Sig. (2-tailed) .683
a  Grouping Variable: group
NN 50 and spectral powers of RR intervals during supine rest. Data are expressed as 
median, minimum – maximum.
N Mean Std. Deviation Minimum Maximum
NN50 50 88.84 59.93 0 198
LF power (ms2) 50 475.38 692.55 24 4246
HF power (ms2) 50 452.76 403.55 37 1719
TOTAL (ms2) 50 928.14 957.64 70 5216
GROUP 50 1.50 .50 1 2
 NN50 LF HF TOTAL
Mann-Whitney U 207.000 300.500 252.000 264.500
Z -2.047 -.233 -1.174 -.931
Asymp. Sig. (2-tailed) .041 .816 .240 .352
a  Grouping Variable: group
Table 12
Heart rate and heart rate variability indices during standing.  Data are expressed as mean 
+ SD, 95% confidence interval of the mean.
Parameters Group N Mean Std. Deviation
Student
t-test
Mean HR (bpm) Control 25 86.17 11.76
t=0.57
P=0.56
Study 25 84.09 14.05
Mean RR  (ms) Control 25 707.72 89.76 t=0.83P=0.41Study 25 737.24 153.64
SDNN (ms) Control 25 43.40 16.55 t=1.04P=0.31Study 25 48.36 17.30
LF power (ms2) Control 25 435.12 349.62 t=0.52P=0.61Study 25 491.52 413.55
HF power (ms2) Control 25 194.60 240.35 t=0.16P=0.87Study 25 184.96 170.09
TOTAL power 
(ms2)
Control 25 629.72 550.07 t=0.31
P=0.76Study 25 676.48 510.41
LFnu Control 25 72.73 12.75 t=0.13P=0.89Study 25 73.22 12.70
HFnu Control 25 27.23 12.79 t=0.99P=0.33Study 25 41.73 57.40
LF/HF Ratio Control 25 3.65 2.55 t=0.11P=0.91Study 25 3.73 2.44
NN50 Control 25 34.52 38.08 t=0.30P=0.77Study 25 37.60 35.74
HF special power and total special power did not follow a normal distribution.  
Normality test-One-Sample Kolmogorov-Smirnov Test
 HF HRV TOTAL Power
N 50 50
Normal Parameters(a,b) Mean 189.78 653.10
 Std. 
Deviation 206.131 525.705
Most Extreme Differences Absolute .227 .163
 Positive .227 .163
 Negative -.188 -.129
Kolmogorov-Smirnov Z 1.603 1.149
Asymp. Sig. (2-tailed) .012 .142
a  Test distribution is Normal.
Descriptive Statistics
NN50 and spectral powers of RR intervals during standing. Data are expressed as 
median, minimum – maximum.
N Mean Std. Deviation Minimum Maximum
LF power (ms2) 50 463.32 380.071 44 1558
HF power (ms2) 50 189.78 206.131 7 1052
TOTAL power 
(ms2) 50 653.10 525.705 58 2209
NN50 50 36.06 36.587 0 164
Group 50 1.50 .505 1 2
Test Statistics(a)
 
LF power 
(ms2)
HF power 
(ms2)
Total power 
(ms2) nn50_hrv
Mann-Whitney U 282.500 285.500 290.000 291.500
Wilcoxon W 607.500 610.500 615.000 616.500
Z -.582 -.524 -.437 -.408
Asymp. Sig. (2-
tailed) .560 .600 .662 .683
NN 50 and spectral powers did not follow normal distribution.  NN 50 and LF spectral 
power were analysed by Mann – Whitney Test. 
Table 13
Summary of changes in heart rate and heart rate variability indices during standing. 
Data are expressed as mean +SD.
G
ro
u
p
Parameters Mean N Std. Deviation
Paired
t-test
C
on
tr
ol
                   
Pair 1  Mean HR (Supine) 68.66 25 10.47 t=9.88
P=0.001MEAN HR (Standing) 86.17 25 11.76
Pair 2 MEAN RR (Supine) 881.92 25 125.45 t=9.68
P=0.001Mean RR (Standing) 707.72 25 89.76
Pair 3 SDNN (Supine) 52.32 25 18.70 t=2.84
P=0.003SDNN (Standing) 43.40 25 16.55
Pair 4 LF power (ms2) (Supine) 363.44 25 235.303 t=1.41
P=0.17LF power (ms2) (Standing) 435.12 25 349.629
Pair 5 HF power (ms2) (Supine) 506.64 25 419.67 t=4.67
P=0.005HF power (ms2) (Standing) 194.60 25 240.35
Pair 6 TOTAL power (ms2) (Supine) 870.08 25 602.516 t=3.05
P=0.001TOTAL power (ms2) (Standing) 629.72 25 550.078
Pair 7 LFnu (Supine) 32.79 25 15.44 t=8.29
P=0.001LFnu (Standing) 72.73 25 12.751
Pair 8 HFnu (Supine) 55.19 25 15.44 t=8.30
P=0.001HFnu (standing) 27.23 25 12.791
Pair 9 LF/HF (Supine) 1.04 25 .98 t=5.29
P=0.001LF/HF (Standing) 3.65 25 2.55
Pair 10 NN50 (Supine) 106.40 25 61.033 t=6.56
P=0.001NN50 (Standing) 34.52 25 38.082
St
ud
y
Pair 1 Mean HR (Supine) 71.97 25 11.00 t=4.75
P=0.001Mean HR (Standing) 84.09 25 14.05
Pair 2 Mean RR (ms) (supine) 824.54 25 227.977 t=1.92
P=0.07Mean RR (ms) (standing) 737.24 25 153.643
Pair 3 SDNN (ms) (Supine) 53.24 25 27.93 t=1.14
P=0.27SDNN (ms) (Standing) 48.36 25 17.30
Pair 4 LF power (ms2) (Supine) 587.32 25 947.50 t=0.61
P=0.54LF power (ms2) (Standing) 491.52 25 413.55
Pair 5 HF power (ms2) (Supine) 398.88 25 387.71 t=2.94
P=0.007HF power (ms2) (Standing) 184.96 25 170.09
Pair 6 TOTAL power (ms2) (Supine) 986.20 25 1225.69 t=1.60
P=0.12TOTAL power  (ms2) (Standing) 676.48 25 510.41
Pair 7 LFnu (Supine) 33.14 25 33.49 t=0.93
P=0.36LFnu (Standing) 76.22 25 12.70
Pair 8 HFnu (Supine) 44.42 25 17.41 t=0.85
P=0.40HFnu (Standing) 41.73 25 57.40
Pair 9 LF/HF Supine) 1.69 25 1.32 t=4.10
P=0.001LF/HF (Standing) 3.73 25 2.44
Pair 10 NN50 (Supine) 71.28 25 54.47 t=3.89
P=0.001NN50 (Standing) 37.60 25 35.74
Changes during standing were analysed by Student’s paired ‘t’ test.
Table 14
Correlations between heart rate and frequency domain indices of heart rate variability. 
Data are expressed as spearman correlation coefficient rs, and P value respectively, 95% 
confidence intervals of Rs are mentioned when P values are ~ 0.05.
G
ro
up Resting 
HR LF Power
HF 
Power
TOTAL 
Power
C
on
tr
ol
          Sp
ea
rm
an
's 
rh
o
           
 Restng HR
 
 
Correlation 
Coefficient 1.000 -.589(**) -.588(**)
-.656(**
)
Sig. (2-tailed) . .002 .002 .000
N 25 25 25 25
LF Power 
 
 
Correlation 
Coefficient
-.589(**
) 1.000 .652(**) .836(**)
Sig. (2-tailed) .002 . .000 .000
N 25 25 25 25
HF Power
 
 
Correlation 
Coefficient
-.588(**
) .652(**) 1.000 .935(**)
Sig. (2-tailed) .002 .000 . .000
N 25 25 25 25
TOTAL 
Power 
 
 
Correlation 
Coefficient
-.656(**
) .836(**) .935(**) 1.000
Sig. (2-tailed) .000 .000 .000 .
N 25 25 25 25
St
ud
y
           
Sp
ea
rm
an
's 
rh
o
           
Resting HR
 
 
Correlation 
Coefficient 1.000 -.557(**) -.646(**)
-.601(**
)
Sig. (2-tailed) . .004 .000 .001
N 25 25 25 25
LF Power 
 
 
Correlation 
Coefficient
-.557(**
) 1.000 .740(**) .923(**)
Sig. (2-tailed) .004 . .000 .000
N 25 25 25 25
HF Power 
 
 
Correlation 
Coefficient
-.646(**
) .740(**) 1.000 .917(**)
Sig. (2-tailed) .000 .000 . .000
N 25 25 25 25
TOTAL 
Power 
 
 
Correlation 
Coefficient
-.601(**
) .923(**) .917(**) 1.000
Sig. (2-tailed) .001 .000 .000 .
N 25 25 25 25
Correlation was assessed by Spearman’s correlation test.  **  Correlation is significant at the 
0.01 level (2-tailed).
Table 15
Correlation between resting systolic blood pressure and measures of overall resting heart 
rate variability.  Data are expressed as Spearman correlation coefficient Rs and P value 
respectively. 95% confidence intervals of Rs are mentioned when P values are ~ 0.05.
Group SBP_R SDNN_R
TOTAL_P
_R
C
on
tr
ol
Sp
ea
rm
an
's 
rh
o SBP
 
 
Correlation 
Coefficient 1.000 -.125 -.090
Sig. (2-tailed) . .553 .668
N 25 25 25
SDNN
 
 
Correlation 
Coefficient -.125 1.000 .860(**)
Sig. (2-tailed) .553 . .000
N 25 25 25
TOTAL Power
 
 
Correlation 
Coefficient -.090 .860(**) 1.000
Sig. (2-tailed) .668 .000 .
N 25 25 25
St
ud
y
Sp
ea
rm
an
's 
rh
o SBP
 
 
Correlation 
Coefficient 1.000 .072 .213
Sig. (2-tailed) . .732 .307
N 25 25 25
SDNN
 
 
Correlation 
Coefficient .072 1.000 .955(**)
Sig. (2-tailed) .732 . .000
N 25 25 25
TOTAL Power
 
 
Correlation 
Coefficient .213 .955(**) 1.000
Sig. (2-tailed) .307 .000 .
N 25 25 25
Correlation was assessed by Spearman’s rank correlation test. 
 **  Correlation is significant at the 0.01 level (2-tailed).
Table 16
Correlation between resting Diastolic blood pressure and measures of overall resting 
heart rate variability.  Data are expressed as Spearman correlation coefficient rs and P 
value respectively. 95% confidence intervals of Rs are mentioned when P values are ~ 
0.05.
Group DBP SDNN TOTAL_P_R
C
on
tr
ol
Spearman's 
rho
DBP Correlation Coefficient 1.000 -.067 -.045
Sig. (2-tailed) . .750 .830
N 25 25 25
SDNN Correlation Coefficient -.067 1.000 .860(**)
Sig. (2-tailed) .750 . .000
N 25 25 25
Total Power Correlation Coefficient -.045 .860(**) 1.000
Sig. (2-tailed) .830 .000 .
N 25 25 25
St
ud
y
Spearman's 
rho
DBP Correlation Coefficient 1.000 -.097 -.015
Sig. (2-tailed) . .644 .945
N 25 25 25
SDNN Correlation Coefficient -.097 1.000 .955(**)
Sig. (2-tailed) .644 . .000
N 25 25 25
Total Power Correlation Coefficient -.015 .955(**) 1.000
Sig. (2-tailed) .945 .000 .
N 25 25 25
Correlation  was  assessed  by  Spearman’s  rank  correlation  test.   **   Correlation  is 
significant at the 0.01 level (2-tailed).
Table 17
Correlation between resting rate pressure product and measures of overall resting heart 
rate variability.  Data are expressed as Spearman correlation coefficient rs and P value 
respectively. 95% confidence intervals of Rs are mentioned when P values are ~ 0.05.
Group RPP SDNN TOTAL Power
C
on
tr
ol
Spearman's 
rho
RPP Correlation Coefficient 1.000
-.537(**
) -.556(**)
Sig. (2-tailed) . .006 .004
N 25 25 25
SDNN Correlation Coefficient
-.537(**
) 1.000 .860(**)
Sig. (2-tailed) .006 . .000
N 25 25 25
TOTAL 
Power
Correlation 
Coefficient
-.556(**
) .860(**) 1.000
Sig. (2-tailed) .004 .000 .
N 25 25 25
St
ud
y Spearman's 
rho
RPP Correlation Coefficient 1.000
-.509(**
) -.423(*)
Sig. (2-tailed) . .009 .035
N 25 25 25
SDNN Correlation Coefficient
-.509(**
) 1.000 .955(**)
Sig. (2-tailed) .009 . .000
N 25 25 25
Total 
Power
Correlation 
Coefficient -.423(*) .955(**) 1.000
Sig. (2-tailed) .035 .000 .
N 25 25 25
**  Correlation is significant at the 0.01 level (2-tailed).
*  Correlation is significant at the 0.05 level (2-tailed).
Table 18
Correlation between resting systolic blood pressure and LF power, and systolic blood 
pressure and HF power.  Data are expressed as Spearman correlation coefficient RS and P 
value respectively. 95% confidence intervals of RS are mentioned when P values are ~ 
0.05.
Group SBP LF Power
HF 
Power
C
on
tr
ol
Spearman'
s rho
SBP
Correlation 
Coefficient 1.000 .193 -.264
Sig. (2-tailed) . .356 .202
N 25 25 25
LF 
Power
Correlation 
Coefficient .193 1.000 .652(**)
Sig. (2-tailed) .356 . .000
N 25 25 25
HF 
Power
Correlation 
Coefficient -.264 .652(**) 1.000
Sig. (2-tailed) .202 .000 .
N 25 25 25
St
ud
y Spearman'
s rho
SBP
Correlation 
Coefficient 1.000 .257 .092
Sig. (2-tailed) . .214 .663
N 25 25 25
LF 
Power
Correlation 
Coefficient .257 1.000 .740(**)
Sig. (2-tailed) .214 . .000
N 25 25 25
HF 
Power
Correlation 
Coefficient .092 .740(**) 1.000
Sig. (2-tailed) .663 .000 .
N 25 25 25
**  Correlation is significant at the 0.01 level (2-tailed).
Table 19
Correlation between resting Diastolic blood pressure and LF power, and Diastolic blood 
pressure and HF power.  Data are expressed as Spearman correlation coefficient rs and P 
value respectively. 95% confidence intervals of Rs are mentioned when P values are ~ 
0.05.
Group DBP LF Power
HF 
Power
C
on
tr
ol
Spearman's 
rho
DBP Correlation Coefficient 1.000 .193 -.113
Sig. (2-tailed) . .356 .590
N 25 25 25
LF Power Correlation Coefficient .193 1.000 .652(**)
Sig. (2-tailed) .356 . .000
N 25 25 25
HF Power Correlation Coefficient -.113 .652(**) 1.000
Sig. (2-tailed) .590 .000 .
N 25 25 25
St
ud
y Spearman's 
rho
DBP Correlation Coefficient 1.000 .017 -.073
Sig. (2-tailed) . .936 .730
N 25 25 25
LF Power Correlation Coefficient .017 1.000 .740(**)
Sig. (2-tailed) .936 . .000
N 25 25 25
HF  Power Correlation Coefficient -.073 .740(**) 1.000
Sig. (2-tailed) .730 .000 .
N 25 25 25
**  Correlation is significant at the 0.01 level (2-tailed).
Table 20
Correlation between deep breathing difference and frequency domain indices of resting 
heart rate variability.  Data are expressed as Spearman correlation coefficient rs and P 
value respectively. 95% confidence intervals of Rs are mentioned when P values are ~ 
0.05.
Group
DB 
MAX/
MIN
LF 
Power
HF 
Power
TOTA
L 
Power
C
on
tr
ol
Spearman'
s rho
DB 
Max/Min
Correlation 
Coefficient 1.000
.
399(*) .108 .165
Sig. (2-tailed) . .048 .608 .430
N 25 25 25 25
LF Power
Correlation 
Coefficient .399(*) 1.000
.
652(**
)
.
836(**
)
Sig. (2-tailed) .048 . .000 .000
N 25 25 25 25
HF Power
Correlation 
Coefficient .108
.
652(**
)
1.000
.
935(**
)
Sig. (2-tailed) .608 .000 . .000
N 25 25 25 25
Total Power
Correlation 
Coefficient .165
.
836(**
)
.
935(**
)
1.000
Sig. (2-tailed) .430 .000 .000 .
N 25 25 25 25
St
ud
y
Spearman'
s rho
D/B 
Max/Min
Correlation 
Coefficient 1.000 .112 -.158 .022
Sig. (2-tailed) . .596 .451 .916
N 25 25 25 25
LF Power
Correlation 
Coefficient .112 1.000
.
740(**
)
.
923(**
)
Sig. (2-tailed) .596 . .000 .000
N 25 25 25 25
HF Power
Correlation 
Coefficient -.158
.
740(**
)
1.000
.
917(**
)
Sig. (2-tailed) .451 .000 . .000
N 25 25 25 25
Total Power Correlation Coefficient .022
.
923(**
.
917(** 1.000
) )
Sig. (2-tailed) .916 .000 .000 .
N 25 25 25 25
*  Correlation is significant at the 0.05 level (2-tailed).
**  Correlation is significant at the 0.01 level (2-tailed).
Table 21
Correlation between resting Rate pressure product and LF power, and Rate Pressure 
Product and HF power.  Data are expressed as Spearman correlation coefficient rs and P 
value respectively. 95% confidence intervals of Rs are mentioned when P values are ~ 
0.05.
Group RPP LF Power
HF 
Power
C
on
tr
ol
Spearman's 
rho
RPP
Correlation 
Coefficient 1.000 -.385
-.617(**
)
Sig. (2-
tailed) . .058 .001
N 25 25 25
LF Power
Correlation 
Coefficient -.385 1.000 .652(**)
Sig. (2-
tailed) .058 . .000
N 25 25 25
HF Power
Correlation 
Coefficient
-.617(**
) .652(**) 1.000
Sig. (2-
tailed) .001 .000 .
N 25 25 25
St
ud
y Spearman's 
rho
RPP
Correlation 
Coefficient 1.000 -.347
-.519(**
)
Sig. (2-
tailed) . .089 .008
N 25 25 25
LF Power
Correlation 
Coefficient -.347 1.000 .740(**)
Sig. (2-
tailed) .089 . .000
N 25 25 25
HF Power
Correlation 
Coefficient
-.519(**
) .740(**) 1.000
Sig. (2-
tailed) .008 .000 .
N 25 25 25
**  Correlation is significant at the 0.01 level (2-tailed).
RESULTS
A list of tables are mentioned in pages 30 to 48. The anthropometric characteristics of subjects  
are given in table – 1. Baseline blood pressure and heart rate are mentioned instable 2. The results of 
cardiovascular functions test  are presented in table 3 to 9.  To find out the difference between the 
groups.  I  have  made use  of  paired  ‘t’ test.  Results  of  HRV and other  correlations  are  done using 
spearman’s rank correlation test.
Results  of  heart  rate  variability  analysis  are  presented  in  tables  from 10  -  13.  Results  of 
correlation between resting HR, BP, deep breathing (db) and HRV indices are presented in tables 14 to 
21.  All reported P values are two – tailed.
My primary  aim has  been  to  compare  autonomic  functions  in  off  springs  of  hypertensive 
parents.  I  have  used  unpaired  students  ‘t’  test  excepting  where  the  compared  variances  were 
inhomogeneous. In that case I have used the Mann Whitney test.
1) Anthropometric Measurements Table - 1
There  was no difference  between the  control  and study group with  regards  to  age,  height, 
weight and BMI (P > 0.05).
2) Resting BP and HR in supine position Table -2
There was no significant difference between the control and study group with regards to HR, 
BP, PP, RPP (P > 0.05).
3) HR and BP response on 2 minutes on standing Table – 3
Both control and study group showed a very highly significant increase in HR, BP, RPP during 
standing (p < 0.001).
4) Percentage changes in HR, BP during standing compared to base line  Table -4.
a) There was a significant increase in HR and SBP in study group immediately on standing ( p< 0.05).
b) There was highly significant increase in DBP of study group immediately on standing. ( p < 0.01).
c)  The percentage increase in HR, SBP, DBP and RPP of both the control and study group were not 
significant (p < 0.05). Although there was a greater increase of the above variables in the control group 
compared to the study group.
d) Percentage increase in RPP in the study group was very highly significant immediately on Standing 
(p < 0.01).
5) HR & BP changes during SIHG Table – 5
The HR, SBP, DBP and RPP showed a very highly significant increase in the control group 
compared to the study group during SIHG. (p< 0.001). Although the resting HR, SBP, DBP, RPP were 
higher in the study group.
6) HR and BP changes in CPT  Table – 6
The HR, SBP,  DBP and RPP showed very highly significant  increase  in  the control  group 
compared the study group during CPT (p<0.001).  Although the resting HR, SBP, DBP and RPP were 
higher in the study group.
7) Controlled Deep Breathing for 1 minute  Table -7
The mean ratio of maximum / minimum in RR interval during 1 minute of controlled deep 
breathing was highly significant decrease in the study group compared to the control group (p< 0.003).
8) Valsalva Ratio in Valsalva Maneuver   Table – 8.
The mean ratio of maximum / minimum in RR interval during  valsalva maneuver was very 
highly significant decrease in the study group compared to the control group (p<0.001).
9) 30/15 ratio on immediate standing Table – 9
This showed are decrease in the study group compared to the control group which was very 
highly significant (p< 0.001).
10) Mean Resting HR and HRV in supine rest Table – 10.
a) HR / minute  in the study group shown increased compared the control group which was statistically 
insignificant ( p< 0.05).
b)  The  mean  RR  interval  of  the  study  group  were  lesser  than  the  control  group  
     (p < 0.05).
c) SDNN (ms) shown that there was no significant change in between the study group and control  
group.
d) LF ms2  in the study group showed an increase on standing when compare to the control group. 
e) HF power . The HF power showed a decrease in the study group when compare to the control group.  
(p < 0.05)
f) Total power showed an increase in the study group was statistically insignificant.(p < 0.05).
g) LF (nu) the study group showed a highly significant change ( P< 0.001).
h) HF (nu) there was a significant decrease in HFnu in the study group compared to the control group.
i) LF/ HF ratio  showed a significant increase in the study group compared to the control group.
j) NN50 showed a decrease in the study group compared to the control group.
 Two groups were matched for age and BMI. Between the two groups, difference in baseline 
SBP, DBP, PP and RPP were statistically not significant, But certainly the resting HR, SBP, DBP and  
RPP were higher in study group compared to the control group.
The base line DBP (P=0.07). This may be an expression of early vascular changes in subjects 
with a genetic predisposition to hypertension (Saguaro et al 1995). The difference in the heart rate at 
the end of 5 mts of supine rest were not (P=0.28) significant.
HR and BP response to standing
The HR and BP response to standing in two groups have been assessed by comparing baseline 
HR, BP with HR and BP after 2 minutes of standing (table3). After two minutes of standing all the two 
groups showed a statistically significant increase in the (P=0.001). In all the groups, the percentage 
increment in HR was greatest immediately after standing, whereas the percentage increment in SBP 
and DBP were maximum immediately after standing (table 4). To distinguish different in BP and HR 
reactivity  to  standing,  percentage  changes  in  BP,  HR  and  RPP  from  baseline  were  analyzed 
immediately, after 2 minutes and after 5minutes of standing. Percentage changes were analyzed since 
there  were  significant  differences  in  baseline  BP.  The  control  group showed a  greater  percentage 
increase (20.53+17.2) in HR after 2 minutes. After 5 minutes of standing the control group still showed 
the greatest percentage increase in HR (15.28 + 15.6) with respect to baseline when compared to study 
group. However, this difference was not statistically significant.
Deep breathing:
A controlled deep breathing for one minute between the control (1.342 + 0.13), study group 
(1.198+0.18) (Table 7) Normal values by age for deep breathing difference (db ration) at 16 to.25 years 
age is 1.21 (smith et al 1995). In the control group there was increase in the db ration and in study  
group there was reduction in db ration. There was a significant db ratio reduction in the study compared 
to control group (P=0.003). .
HR and BP response to sustained isometric handgrip:
All two groups showed statistically significant (P=0.001) in HR, SBP, DBP and RPP during 
sustained isometric hand grip (table 5). In both groups RPP remained higher compared to baseline 
(P=0.001). The resting RPP in control group in lower (7089 + 1228) compared to the resting RPP in 
study group (7675 + 1397).
HR and BP response to cold pressor test 
The result of CPT is given in table 6. Both groups showed a statically significant change in the 
RPP. However the resting HR, SBP and DBP higher in the study group compared to the control group.  
There was  no significant change in RPP at the end of CPT.
VALSALVA RADIO IN VALSALVA MANEUVER 
The valsalva ration during (VR) valsalva maneuver of the two groups given in table 8. The VR 
for control is 1.244 + 0.13 and the study group is 1.120 + 0.10. The ratio of 1.2 or greater is thought to  
be normal (Ewings et al 1997) . The control group is higher than the study group compared to the 
standard values. There was  a statistically significant (P 0.001) VR compared in between  two groups.
30:15 RATIO ON IMMEDIATE STANDING.
The cardio vascular response to standing is assessed by 30:15 ratio. The 30:15 ratio of control 
group (1.288 + 0.14), the study group (1.108 + 0.18) (table9). The age related value is 1.07 (Ewings et 
al 1974). Here both the group show above the normal value but when compared in between the two 
groups there in statistically significant 30 : 15 ratio (P=0.001) reduction in the study group compared to 
the control group.
RESULTS OF HEART RATE VARIABILITY.
RESTING HEART RATE VARIABILITY 
The mean RR of  two groups during  5  minutes  of  supine  rest  was comparable  (Table  10). 
Although difference in SDNN between two groups were not significant (P=0.89). Since NN50 Value 
did not follow the normal distribution, they were analyzed by Mann – Whitney test.
The LF powers  at  rest  in  the control  group 363 + 235 m2 the study group 587 + 947 m2 
respectively. The standard deviation is higher because the range is very vide.
The HF power (m2) of control group is 506 + 419 and the HF Power (m2) of study group is 398 
+ 387. This shows there was  a reduction in HF power in the study group which is again analyzed by  
Man- Whitney test. The total power of control and study of mp are 870 + 602, 986 + 1225 respectively. 
When LF powers  and HF Powers  were normalized,  the differences  between two groups were not 
statistically significant. 
 HEART RATE VARIABILITY DURING STANDING 
The mean heart rate and heart rate variability of the two groups during standing are given in 
table 12. The differences in mean RR during standing were not significant.  NN 50 and LF power did 
not follow a normal distribution and have been analyzed by one sample kolmogorov-smirou test.  The 
difference in NN50 between control and study group appears to be clinically important.  NN50 and LF 
power did not follow a normal distribution and so they are analyzed by Kolmogorou-smirou test.  Also, 
the LF power is higher 491+ 413 in the study group compared to control 435 + 349. The total power is 
also increased in study group 676 + 510 compared to control 629 + 550.
In all two groups resting HR and HRV indices have been compared with HR and HRV indices  
during standing ( p = 0.001) also statistically significant total power, HF power, LF nu, HF nu LF / HF 
ratio and NN50.
RESULTS OF CORRELATION BETWEEN RESTING HR, BP, BREATHING DIFFERENCE 
AND HRV INDICES.
The correlation between HR, BP, deep breathing and HRV indices were tested by spearman’s 
rank correlation test. The results are shown in (Table 14-21).
CORRELATION BETWEEN RESTING HR AND FREQUENCY DOMAN HRV INDICES
In  the  control  group  the  negative  correlation  (p=0.002)  between  LF  power  and  HR  was 
significant, also  the negative correlation between HF and total power were significant (p = 0.002).  In 
the study group the negative correlation between LF power and HR was significant (p = 0.004),also 
there was a negative correlation between HF and total power which were significant (p = 0.001).
CORRELATION BETWEEN SBP, DBP, RPP AND HRV INDICES
(Table 15,  16) Broth control  and study group show negative correlations between SBP and 
measures of overall HRV were insignificant.  In the control group, the negative correlation between 
DBP and SDNN was insignificant.  In the control group there was  a negative correlation between RPP 
and total  power which was significant  (p = 0.004).   In  the  control  group the negative  correlation 
between RPP and total power which were not significant.
DISCUSSION
The autonomic nervous system and the balance between PNS and SNS output play an important 
role in overall cardiovascular homeostais. The fact that HRV responses are significantly lower in study 
group in consistent with the prevalence of a hyperdynamic circulatory state during maneuvers such as 
orthostatic load, isometric hand grip, CPT etc.  This fact has been previously noted by (Julius et al  
1990).
There  was  no  clear  evidence  of  a  significant  difference  in  overall  heart  rate  variability  as 
measured by SDNN. Also there was very little difference in the power in respiratory sinus arrhythmia, 
quantified by deep breathing and HF power at rest. However there was significant increase in the low 
frequency modulation of heart rate at rest in study group, this was measured in terms of absolute units 
of power. The LF in nu in the study group at rest was greater compared to control group (Stolorzk et al  
2003). Although SDNN, the square root of variance, is a reliable measure of overall HRV, it does not 
provide any information as to how fast the heart rate response could be mediated.  The other important 
and interesting difference between control and study group was the significant higher LF/HF ratio in 
study group even in supine position. This is due the greater LF modulation and lesser HF modulation of 
HR in the study group. So it was evident that LF modulation was most likely due to the sympathetic 
overactivity  (Taylor  et  al  1996).  This  in  turn  occurs  due  to  centrally  originating  oscillations  in 
sympathetic drive to the blood vessels. This indirectly implicating that the group may become overtly 
hypertensive early in their life  (ES Prakash et al 2004). LF / HF ratio in the supine position during 
normal quit breathing at 12 to 16/min is not a good indicator for sympathovagal interplay as the LF 
component which is a measure of sympathetic activity is very little  during supine  position and most of 
HRV in supine position is due to vagal modulation  which could be abolished by atropine (Pagami et al 
1986).     But the ratio assumes significance on standing since there is either a vagal withdral or an 
increase  or  sympathetic  activity  on  standing   in  the  study  group  where  the  LF/HF  ratio   has 
significantly increased.  
RESTING BP, HR AND SUPINE POSITION
The resting  HR and BP  were  higher  in  the  study group.  Although  they were  statistically 
insignificant, an increase in the diastolic pressure may be an expression of early vascular changes in the 
subjects with  a genetic predisposition to hypertention. (Sagura et al 1995).
HR, BP , RPP response to standing
The HR, BP, RPP showed a very significant increase in both the study and control group during 
standing.  The percentage increase in the HR, BP, SBP, RPP immediately on standing were significantly 
lower in the study group.  Although the percentage change in the  HR, BP, RPP after 2 minutes and 5  
minutes of standing  shown an increase in both group. It was statistically insignificant. The autonomic 
responses triggered to buffer the effects of gravity on the circulation produced by standing are complex, 
relying mainly on functional specialized stretch receptors (baroreceptors) that activate baroreflexes and 
the effects of local venoarteriolar axon reflexes. The exercise reflex (Coote et al 1971), capillary fluid 
shift systems, and the effects of endothelial and  neurohormonal factors that modulate baroreflexes or 
act directly on blood vessels and the heart and kidneys play additional roles in the response to standing 
peripheral vascular resistance increase through sympathetic vasoconstriction and heart rate increases 
due to both vagal withdrawal and sympathetic activation.  The net effect is an increase in heart rate and 
an increase in  blood pressure to  maintain values close to  those while  supine  (although the pulse 
pressure may be diminished) (Rowell 1993).  Simple procedures such as the measurement of upright 
blood  pressure  and  heart  rate  provide  important  information  regarding  the  integrity  of  the  reflex 
mechanism that are triggered to compensate for the effects of gravity on the circulation.
30/15 Ratio on immediate standing
Studying the heart rate during the initial 30 sec after active standing provides an estimate of  
cardiac parasympathetic control as the changes in heart rate are largely mediated by parasympathetic 
withdrawal and activation reflecting the changes in baroreceptor afferent traffic. Continuous heart rate 
recording during the immediate response to standing have demonstrated heart rate peak at 3 and 13 sec 
followed by a slowing at 20 sec.  The first heart rate peak is at about 3 sec due to withdrawl of vagal  
tone.  This is followed by a gradual increase heart rate and a second peak that reaches a maximum at 
about a 12 sec due to both withdrawal of vagal tone and increased sympathetic tone.  Within seconds of 
this initial response, venous return raises due to the pumping effects of limb and abdominal muscle 
contraction during the effort of standing and blood pressure over suits transiently.  This raise in blood 
pressure  is  detected by barorecptors  (barorecptors  are  loaded).   Leading to  reflex  parasympathetic 
activation with slowing of heart rate which reaches a nadir at about 20 seconds (about 30 th heart beat) 
after active standing.  The heart rate variation during is almost completely abolished by atropine, but 
unaffected propranolol, indicating that this it is under vagal control (Ewing et al 1980).  A reproducible 
ratio  calculated  from the  maximum and  minimum RR  intervals  at  about  15  and 30th beats  after 
standing is  frequently used to measure vagal function.  Normally, the ratio is greater than 1.04. In my 
study although both the groups showed a ratio more than 1.04, the study group had a value which was 
highly significantly lower, which could be due to early parasympathetic attenuation. 
BP AND HR CHANGES DURING SUSTAINED ISOMETRIC AND GRIP TEST
Sustained isometric hand grip against resistance causes an increase the HR and arterial blood 
pressure. The cardiovascular response  are mediated partly by central command and partly by metabolic 
or mechanical changes, or both, in contracting muscle that activate small fibres in the afferent limb of 
the reflex arc. Sustained muscle contraction causes increased BP and HR as a result of exercise reflex 
which withdraws parasympathetic and increases sympathetic activity.  The BP changes are regulated by 
sympathetic adrenergic vascular function and the heart rate changes by parasympathetic cholinergic 
(Cardiovagal) function. This is well documented in our study where there is increase in HR, BP and 
RPP  in  the  control  group whereas  the  study group did  not  show a  significant  increase  in  above 
parameters.  
BP AND HR CHANGES DURING COLD PRESSOR TEST 
The  normal  response  to  immersion  of  a  hand  in  ice  water  involves  reflex  arterial 
vasoconstriction producing increase in blood pressure and cardiac output by cutaneous pain receptors. 
Blood pressure is raised mainly through increased vascular resistance due to enhanced sympathetic 
activity.  The initial increase in heart rate is blunted by β  - adrenoreceptor blockers  suggesting that 
sympathetic rather than parasympathetic outflow mediates this response.  While the cold pressor test 
has been used to assess the efferent sympathetic outflow, the response involves a reflex arc that inclues 
afferent sensory nerve (pain), spinothalamic tracts, suprapontine and intrathalamic relays in addition to 
efferent sympathetic pathways, peripheral sympathetic receptors.  Our study confirms the earlier works 
that there was a decrease in RPP in the study group which possibly due to reduced HRV immediately 
following the maneuver (ES Prakash et al 2004).
OVERALL HEART RATE VARIABILITY :
The differences  in  SDNN were not  statistically significant.  The overall  SDNN in  both  the 
groups were more than 50 milliseconds at supine rest. The SDNN computed for 24 hours is a good 
predictor for mortality after myocardial infarction (ATRAMI Study 1998).    
FREQUENCY DOMIN INDICES OF HRV
The short term (5minutes) ECG recording (Task force 1996) gives the mechanisms influencing 
heart period modulation. HRV occurring in the frequency range 40-400 MHz is mainly due to two 
important mechanisms – tonic vagal activity and reflex vagal activity. It is necessary to appreciate and 
understand that power with in this range (40-400 MHz) signifies the extent to which HR is modulated 
by acetylcholine released upon stimulation of instantaneous heart rates and it is also quite dependent 
upon the sensitivity of effectors to acetylcholine. It does not imply and also do not correlate with vagal 
traffic. So vagal tone is better quantified by change in heart rate induced by atropine following total  
beta blockade (Steinpk et al  2005). But in our study we found the total power is increased in the study 
group both in supine and standing position. If NN 50 in the measure of vagal activity it is very clearly 
and significantly increased in the control group compared to the study group in supine position. This 
indicates that there is early vagal attenuation occurs in the study group at this age itself. (Task force 
1996) report.
CORRELATION BETWEEN BLOOD PRESSURE  AND HRV INDICES 
Both SBP and DBP were higher in the study group even at supine rest (Marer JR et al 2004) and 
there was a negative correlation between SDNN and DBP in both the groups. The resting RPP was 
higher in the study group. The negative correlation between RPP and total power suggests that the 
common denominator between the two is the activation of the sympathetic nervous system. RPP is 
taken RPP as a simple index of myocardial oxygen consumption, the sympathetic effect on the CV 
system,  then  its  negative  correlation  with  HRV  indices  was  quite  understandable.  Significant 
correlation between heart rate, RPP, deep breathing, and frequency domain indices of HRV support the 
easy approach in the evaluation of autonomic function. 
HEART RATE VARIABILITY DURING DEEP BREATHING
The normal value for deep breathing for age group 18 – 25 years was 1.21 (Smith et al 1995).  
In our study the control group showed a deep breathing of 1.34.  The slight increase was due to ethnic 
variation.  A significant decrease of DB in the study group is a sensitive, specific and reproducible 
measure of cardiac vagal function, which acts centrally as well as peripherally. The decrease in the DB 
in the study group may be due to reduced baroreflex sensitivity or impaired vagal afference to the brain 
or an impaired ability of the brain stem to recognize  the different signals resulting in an altered efferent 
signal to the heart a produce decreased cardiac parasympathetic activity (Hirsch JA et al 1981).
Measuring heart rate variability during 1 minute of controlled deep breathing (6 cycles 1 mt) is 
a sensitive, specific and reproducible measure of cardiac vagal function. The db in the control was 1.34 
+ 0.13 and in study group it was 1.19 + 0.18. There was a very high significant (P<0.001) reduction in 
the study group. The basis of this finding was mainly vagus which has got multiple levels of nuroaxis  
including peripheral and central mechanisms. 
The PNS to heart may be decreased, may be due to reduced Baroreflex sensitivity, impaired 
vagal afferents to the brain, and impaired ability of the brainstem to properly recognize the different 
signal and hence altered efferent signals to the heart to decrease cardiac parasympathetic actively. The 
findings of this study correlate (Hirsch. JA et al 1981).
HEART RATE RESPONSE TO VALSALVA MANEUVER 
During  valsalva  maneuver  there  are  changes  in  cardiac  vagal  efferent  and  sympathetic 
vasomotor activity, resulting from stimulations of carotid sinus and aortic  arch baroreceptors and other 
intrathoric stretch receptors. The valsalva ratio is the measure of both parasympathetic and sympathetic 
function. In my study the valsalva ration (VR) for control group (1.24 + 0.13) and study group was 
(1.12 +0.10). There is statistically significant reduction in the study group. The VR of 1.2 or more in 
thought to be normal (Ewings et al  1977). Then the study group is well below the value of 1.2.
The factors in combinations may tend to decrease left ventricular output during the strain of the 
valsalva maneuver and decreased evoked tachycardia and vasoconstriction. So falling VR in the study 
group is the early physiological adaptation of chromic volume overloads state.
It is indeed necessary to control the BP at an optimum limits. Over many years adequate control 
of BP meant a clinic reading <140/90 mmHg obtained in the sitting position. But it is necessary to 
assess cardiovascular reactivity to such laboratory stressors in as much as these mimic the activity of 
daily life like standing, sustained isometric handgrip, cold pressor test, mental arithmetic are simple, 
laboratory physiologic equivalents of activities of daily life and it may be more useful to assess BP 
responses to such activity rather than assess the resting blood pressure alone (ES Prakash et al 2004).
The reasons for employing battery of autonomic function test takes time to perform and often 
require  sophisticated and expensive equipment  and software for data  acquisition and analysis.  The 
interpretation is often difficult since the underlying physiological mechanism are not really understood. 
In view of the complex nature of the hypertensive phenotype, it is very difficult to make generalization 
about  the  predictions  of  further  hypertensive.  Since  it  appears  that  the  genesis  of  most  primary 
hypertension has its base in the central nervous system, it is worth to examine autonomic profile in the 
offsprings of Hypertensive parents who my develop hypertension in near future. 
Ewings  test  –  use  fullness  in  assessing CV autonomic function in  normotensive  hypertensive 
subjects
These  test  are  useful  in  evaluating  CV  autonomic  function  in  normotensive  hypertensive 
subjects.  The  pressor  responses  are  mediated  by  the  sympathetic  nervous  system  and  heart  rate 
responses are for most part, vagally mediated (Stephen et al 2002)..
HOW FOR HRV ANALYSIS IS USEFUL IN THE EVALUATION OF OUR SUBJECTS.
Autonomic  function  evaluations  with  HRV analysis  is  not  without  problems.  The  indices 
obtained are very complex and any valued interpretation needs a clear knowledge of mechanisms of 
cardiovascular regulation. Many times I come across an open – ended questions and interpreting HRV 
analysis is not an easy task. Single measurements is even more difficult to interpret since there are wide 
variation in most of the HRV indices. HRV analysis requires well advanced data acquisition systems 
and expensive software and persons trained to analyze and interpret the result. The autonomic state that 
exists in a normotensive is influenced by a number of factors including physical activity, duration of 
changes and presence of other risk factors of cardiovascular systems.
CONCLUSION
Cardiovascular autonomic function in normotensive hypertensive subjects have shown 
 Significant increase in LF power in HRV 
 Very slight decrease in overall heart rate variability in study group
 The increase of LF modulation and RR interval as a decrease in overall HRV (an indicator 
of decreased baroreflex sensitivity) may be due to centrally originating  sympathetically 
mediated BP oscillation.  This may be an early prediction of normotensive hypertension 
concept. 
 The  cardiovascular  autonomic  function  and  HRV  analysis  provided  an  additional 
information about the normotensive hypertensive concept. 
 The following are very significantly decreased in the study group,
o 30/15 ratio on immediate standing
o Deep breathing (maximum / minimum RR interval)
o VR ratio in valsalva meneuver
 Further study along these lines could give more information in understanding cardiovascular 
autonomic function in clinical settings. 
SUMMARY
This study was aimed to compare the CV autonomic function in subjects with offsprings of 
hypertensive to offsprings of nonhypertensive nondiabetic parents. The subjects were divided into two 
groups of 25 males of age group 18-25 years.  
Control group – offsprings of nonhypertensive  nondiabetic parents      
Study group – Offsprings of  hypertensive  nondiabetic parents. 
The following tests were performed:
• Blood Pressure and HR Response at supine rest
• Blood Pressure and HR Response during quite standing.
• Controlled deep breathing 1 minute
• Valsalva ratio in valsalva maneuver 
• Sustained isometric hand grip test.
• Cold pressor test.
The following results were obtained :
• 30 : 15 ratio on standing(very high significant reduction in study group)
• Deep breathing for 1 minute max RR / minim RR (significant reduction in study group)
• Valsalva ratio (VR)(very high significant  reduction in study group) 
• RPP was more at the rest in the study group, but no significant changes during SIHG and CPT.
The following results were obtained in HRV analysis:
• The mean RR is increased in the study group 
• SDNN there is no very much difference 
• LF power increased in the study group
• HF decreased in the study group.
• Total power increased in the study group
• LFnu increased in study group on standing 
• HFnu decreased in study group on standing
All these observations indicate very early small reduction in vagal modulation of RR intervals 
in the study group. An increase in LF Power in the study group gives an idea of sympathetic over 
activity. But there is no clear evidence of increased sympathetic activity at this stage.
So bedside assessment of measuring blood pressure  alone may not reflect the actual physiology 
in the prediction of normotensive hypertensive concept. But on the other hand the autonomic function 
test  and HRV analysis  could also  give more  information in  understanding the regulation  of  blood 
pressure.  
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NAME OF THE STUDENT:
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ROLL NO. :
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DATA OF THE PARENT :
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ADDRESS OF THE PARENT :
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APPENDIX D
Consent Form
I   Mr.  ______________________________________Understand  that  Dr. 
xxxxxxx, a postgraduate student in Stanley Medical  College and Hospital, Chennai is 
doing  this  study  on  subjects  with  Normotensive  Hypertensive.   I  am  given  to 
understand that these tests will assess the functioning of my heart and blood vessels. 
These  tests  are  simple;  involve  taking  ECGs,  blood  pressure  and  respiratory 
movements. They do not involve injections or taking any medicines and are risk free. 
I have been familiarized with the testing procedures.  I am participating in this study 
willingly.  I have not been forced to do so.  I have also been told clearly that I could 
withdraw from this study without any prejudice.
Date :
Signature :  
 
APPENDIX C
Proforma used for data collection in Normotensive Hypertensive Subjects.
Department of Physiology, S.M.C., Chennai.
Name Age Gender
Date Time Group
Weight (kg) Height (m) BMI
Conditions Consent DBD
Heart Rate variability analysis 
Parameter Supine Rest (256 s) Standing (256 s)
Mean RR (ms)
SDNN (ms)
LF Power (ms2)
HF Power (ms2)
Total Power (ms2)
LF / HF (ms2)
LF nu / HF nu 
NN 50
BP and HR response to standing
Parameter SBP DBP HR RPP
Resting Supine
Upon standing (immediate)
(Within 5 seconds) 
2 min after standing
5 min after standing
30 / 15 ratio 
Deep breathing difference
Valsalva Ratio 
BP and HR response to sustained isometric Handgrip
Parameter SBP DBP HR RPP
Resting
After 1 min of handgrip
BP and HR response to cold pressor test
Parameter SBP DBP HR RPP
Resting
After 1 min of immersion in 
cold water
Signature :
LIST OF ABBREVIATIONS
AV - Analysis of Variance
ACE - Angiotensin Converting Enzyme
ANFT - Autonomic Function Test 
ANS - Autonomic Nervous System
AV - Atrio Ventricular
BP - Blood Pressure
BPM - Beats Per Minute
BPR - Blood Pressure Response
CNS - Central Nervous System 
CO - Cardiac Output
CPT - Cold Pressor Test
CV - Coefficient of Variation
DBD - Deep Breathing Difference
DBP - Diastolic Blood Pressure 
DMV - Dorsal Motor Nucleus of Vagus
ECG - Electrocardiogram
FFT - Fast Fourier transform  
HF - High Frequency
HR - Heart Rate
HRV - Heart Rate Variability 
HT - Hypertension
IML - Inter Mediolateral 
IVC - Inspiratory Vital Capacity
LF - Low Frequency
MI - Myocardial Infarction
NE - Nor epinephrine
NN50 - Normal to normal RR interval deviation 
more than 50 ms.
NTS - Nucleus Tract us Solitaries
OHTP - Offspring of Hypertensive Parents
ONHTP - Offspring of Non Hypertensive Parents
PNS - Parasympathetic Nervous Systems
PSD - Power Spectral Density
PTI - Postural Tachycardia Index
RHR - Resting Heart Rate
RPP - Rate Pressure Product
RRI - RR interval 
SA - Sino Atrial Node
SBP - Systolic Blood Pressure 
SD - Standard deviation
SDNN - Standard Deviation of Average Normal to 
Normal RR Interval 
SIHG - Sustained Isometric Handgrip Test 
SMC - Stanley medical college
SNS - Sympathetic Nervous System
TPR - Total Peripheral Resistance
TV - Tidal Volume
VC - Vital Capacity
VLF - Very Low Frequency
VLM - Ventro Lateral Medulla
VM - Valsalva Maneuver 
VR - Valsalva Ratio
ms2 - Milliseconds Squared 
r - Supine rest
Si - Standing immediate 
S2 - Standing 2 minutes
S5 - Standing 5 minutes
